The Boston Examiner
SEE OTHER BRANDS

The most trusted news from Massachusetts

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on October 1, 2025

Exergen Drives Growth with Global Expansion
Quest Travel Adventures Announces New 2026 Atlantic Island Itineraries to the Azores, Madeira & Canary Islands
60% of Local Government Finance Leaders Call Modernization Top Priority for Next Year, New Study Finds
PharmStars Announces 9th Cohort Launch and Pharmatech Innovation Summit Focused on Data Management, Insights, and AI
Thrive Appoints Kirti Gavri as SVP, Head of Corporate Development
Ernexa Therapeutics to Deliver Company Presentation at the Annual Cell & Gene Meeting on the Mesa
Shoppers Plan to Spend More in 2026, but Loyalty Is Up for Grabs
Sophos Launches Advisory Services to Deliver Proactive Cybersecurity Resilience
Avalyn Appoints Industry Veterans Jill Denning and Kimberley Cummings to Leadership
CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
Solid Biosciences to Present at Upcoming Scientific Meetings
DraftKings Teams Up with The Larry Fitzgerald Foundation, Turning Picks into Breast Cancer Awareness and Support
Crane NXT Announces Appointment of Kim DiMaurizio as Senior Vice President and Chief People Officer
Neumora Therapeutics to Host Virtual R&D Day on October 27
Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer
C4 Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Pfizer for the Combination of Cemsidomide and Elranatamab for the Treatment of Relapsed/Refractory Multiple Myeloma
AMG and Brown Brothers Harriman Announce Strategic Collaboration
Rapid7 Announces Strategic Expansion into the UAE to Support Region's Cybersecurity Growth and Digital Vision

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions